Blog

Do not miss our news. Follow the trends.

Cancer medicine, Lartruvo (olaratumab), does not prolong life

Cancer medicine, Lartruvo (olaratumab), does not prolong life

In a recent phase 3 clinical trial, Lartruvo (olaratumab)’s manufacturer stated that the medicine failed to confirm its clinical benefit in combination with a chemotherapy medication for patients with advanced or metastatic soft tissue sarcoma (STS). There were no significant differences between combining Lartruvo (olaratumab) with chemotherapy or treating patients with chemotherapy on its own. Click here for more information. In the meanwhile, the European Medicines Agency (EMA) and US Foo... Read More...

Cancer free

Cancer free

Fresh and good medications Dolorem, sapiente tincidunt, officia luctus, luctus excepturi laoreet libero purus voluptatem, tempor ea, placerat porttitor dignissim? Magni aenean pellentesque id incididunt voluptate? Odio. Arcu. Tempora massa minima ac, ipsam donec recusandae? Hendrerit aptent quia justo voluptatum wisi pede quia optio, ligula saepe cumque architecto. Sunt error fringilla laboris varius molestie. Montes aptent, porro auctor, felis ridiculus. Tincidunt molestie. Deleniti quide... Read More...

  • 1